THOMAS PHD ADAMS
CIK 1234366 · Executive Chairman · last filed 2021-06-14
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$29.1K
Companies
7
Total Filings
51
Lifetime Open-Market Net
-$137.2K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CRDF | Executive Chairman | 18,875 | $1.54 | $29.1K | $20.0K | 3 | 2021-06-14 |
| HEPA | Director | — | $0.08 | — | $0 | 4 | 2021-05-20 |
| Cardiff Oncology, Inc. (TROV) Delisted | Chief Executive Officer | 351,959 | — | — | $0 | 5 | 2019-06-24 |
| SYNERGY PHARMACEUTICALS, INC. (SGYP) Delisted | Director | 100,023 | — | — | $0 | 3 | 2018-07-06 |
| Cardiff Oncology, Inc. (TROVW) Delisted | Director | 330,686 | — | — | -$157.2K | 7 | 2017-01-05 |
| SYNERGY PHARMACEUTICALS, INC. (SGYPW) Delisted | Director | — | — | — | $0 | 7 | 2016-06-29 |
| LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Director | — | $6.22 | — | $0 | 2 | 2008-05-23 |
Recent Filings · Page 3 of 6
51 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-07-28 | SYNERGY PHARMACEUTICALS, INC. (SGYPW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-03-19 | Cardiff Oncology, Inc. (TROVW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-12-09 | SYNERGY PHARMACEUTICALS, INC. (SGYPW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-02-26 | Cardiff Oncology, Inc. (TROVW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-09-04 | Cardiff Oncology, Inc. (TROVW) Delisted | Sell (S) | −19,200 | -$157.2K | EDGAR |
| 2013-07-16 | SYNERGY PHARMACEUTICALS, INC. (SGYPW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-02-21 | Cardiff Oncology, Inc. (TROVW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-11-01 | — | Mixed | −238,755 | -$5.23M | |
| 2012-10-02 | — | Exer (M) | +293 | $0 | |
| 2012-08-09 | SYNERGY PHARMACEUTICALS, INC. (SGYPW) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.